← Open Payments lookup

JENNIFER WATSON: Open Payments

NPI 1750344834 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,193 in 125 payments from 18 companies in 2025. Trend: 2023 $1,181 · 2024 $5,360 · 2025 $10,193

Consulting: $6,479Food & beverage: $2,317Travel & lodging: $1,364Education: $34
CompanyPaymentsAmount
CSL Behring13$8,197
AstraZeneca Pharmaceuticals LP17$429
GlaxoSmithKline, LLC.23$339
GENZYME CORPORATION14$222
Takeda Pharmaceuticals U.S.A., Inc.13$200
Novartis Pharmaceuticals Corporation17$177
BioCryst US Sales Co., LLC3$93
Regeneron Healthcare Solutions, Inc.3$73
Lilly USA, LLC3$72
ARS Pharmaceuticals Operations, Inc.3$68

Products named: Andembry, TEZSPIRE, DUPIXENT, NUCALA, CUVITRU, TRELEGY ELLIPTA, ORLADEYO, Hizentra.

Industry payments across ID — which companies pay providers there.